[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353138-105":59,"doc-detail-353138-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rilpl2-suppresses-metabolic-reprogramming-and-progression-of-cervical-cancer-by-attenuating-ldha-protein-stability-and-inhibiting-h3k18-lactylation","RILPL2 suppresses metabolic reprogramming and progression of cervical cancer by attenuating LDHA protein stability and inhibiting H3K18 lactylation","","Cervical cancer shows high incidence and mortality, and new therapies are urgently needed. Research identifies RILPL2 as downregulated in cervical cancer and linked to favorable outcomes. Mechanistically, RILPL2 interacts with LDHA and recruits TRIM21 to promote K48-linked ubiquitination and LDHA degradation, blocking glycolytic reprogramming and restricting tumor progression. This glycolysis suppression reduces lactate production, decreases H3K18 lactylation, downregulates SOX9 and SMYD2, and suggests RILPL2 as a therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rilpl2-suppresses-metabolic-reprogramming-and-progression-of-cervical-cancer-by-attenuating-ldha-protein-stability-and-inhibiting-h3k18-lactylation/353138/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rilpl2-suppresses-metabolic-reprogramming-and-progression-of-cervical-cancer-by-attenuating-ldha-protein-stability-and-inhibiting-h3k18-lactylation/353138.png","ImageObject",300,407,{"name":92,"@type":93},"4398046744996","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the research focus regarding RILPL2 in cervical cancer?","Question",{"text":112,"@type":113},"The study investigates how RILPL2 affects metabolic reprogramming and cervical cancer progression, and whether it can act as a therapeutic target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does RILPL2 influence LDHA in the proposed mechanism?",{"text":117,"@type":113},"RILPL2 recruits TRIM21 to promote K48-linked ubiquitination of LDHA, leading to reduced LDHA protein stability and degradation.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is H3K18 lactylation important in this study?",{"text":121,"@type":113},"The work links inhibition of glycolysis and reduced lactate production to decreased H3K18 lactylation, which contributes to downregulation of SOX9 and SMYD2 and suppresses tumor progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353138,1790128463,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":66,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":138,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4398046744996,"[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nRILPL2 suppresses metabolic reprogramming and progression of cervical cancer by attenuating LDHA protein stability and inhibiting H3K18 lactylation  \nYujing Shi1,5, Zhaoyue Zhang2,3,5, Jin Liu2,5, Caiqiang Zhu 1,5, Gefenqiang Shen3, Meng Tian3, Liang Liang 1, Jinhui Liu4 ✉ and Xiaoke Di 2,3 ✉  \n© The Author(s) 2026  \n|  |  |  |\n| --- | --- | --- |\n|  | Cervical cancer (CC) is a prevalent malignancy among women worldwide with considerable incidence and mortality. Recent studies have suggested that the Rab-interacting lysosomal protein-like 2 (RILPL2) acts as a tumor suppressor and plays an inhibitory role in multiple human cancers. However, the potential effect of RILPL2 in CC remains unclear. In our investigation, we found that RILPL2 was downregulated in CC samples and was associated with a favorable outcome. Further ﬁndings indicated the interaction between RILPL2 and lactate dehydrogenase A (LDHA), a crucial player regulating glycolysis. Mechanistically, RILPL2 reduced LDHA stability by recruiting TRIM21 to facilitate K48-linked ubiquitination chains of LDHA and promoting LDHA degradation, thereby blocking glycolytic reprogramming and, in turn, inhibiting CC progression and development. Moreover, RILPL2-mediated inhibition of the glycolytic pathway could restrain lactate production, which abolished H3K18 lactylation to induce the downregulation of SOX9 and SMYD2 . Consequently, our results suggested that RILPL2 may serve as a potential therapeutic target for the treatment |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| of CC. |  |  |\n|  | Cell Death and Disease (2026)17:590; [https://doi.org/10.1038/s41419-026-08808-9](https://doi.org/10.1038/s41419-026-08808-9) |  |\n|  |  |  |\n\nINTRODUCTION  \nCervical cancer (CC) represents a substantial global public health challenge, with a large number of new cases and deaths occurring globally each year [1–3] . The occurrence of CC is notably elevated in low- and middle-income nations, where the availability of screening and vaccination initiatives is constrained [4, 5] . Despite advancements in early detection and treatment, including surgery, radiotherapy, and chemotherapy, the outlook for patients diagnosed at this stage continues to be unfavorable, highlighting the critical necessity for the development of novel therapeutic strategies [6–8] .  \nAccumulating research has underscored the essential effect of metabolic reprogramming in tumor progression, suggesting that altered cellular metabolism is not merely a consequence of tumorigenesis but may actively contribute to tumor survival and development [9–12] . Cancer cells accelerate malignant progression by modulating glucose metabolism, with glycolysis serving asa major energy-producing pathway that is essential for tumor proliferation and metastasis [13–16] . For instance, NAT10 was found to promote glycolytic metabolism to facilitate cell growth, metastasis, as well as immunosuppression in CC by enhancing FOXP1 transcription [17] . Chen et al. reported that TRIM33 could boost glycolysis through increased ubiquitination with P53,  \nthereby promoting esophageal cancer growth and progression [18] .  \nMoreover, lactate, the ﬁnal byproduct of glycolysis, serves asigniﬁcant regulatory function in tumor progression [19–21] . Recently, it was uncovered that lactate-mediated lactylation of histone could regulate the expression of downstream targets, thereby promoting tumorigenesis, invasion and metastasis [22–25] . As revealed by Li et al., lactylation of H3K18la could confer immunotherapeutic resistance by promoting RUBCNL expression and activating cell autophagy in colorectal cancer [26] . In lung cancer, H3K18la lactylation level was strongly associated with worse clinical outcome and contributed to cellular immune escape through activation of POM121/MYC/ PD-L1 axis [27] . However, the underlying mechanisms by which C","cbCaikwwq4HvFawQ","https://ap.wps.com/l/cbCaikwwq4HvFawQ","pdf",9531846,15,"English","# Introduction\n## Metabolic reprogramming and glycolysis in cervical cancer\n## Lactate-mediated histone lactylation and tumor progression\n## RILPL2 background and rationale for investigation","[{\"question\":\"What is the research focus regarding RILPL2 in cervical cancer?\",\"answer\":\"The study investigates how RILPL2 affects metabolic reprogramming and cervical cancer progression, and whether it can act as a therapeutic target.\"},{\"question\":\"How does RILPL2 influence LDHA in the proposed mechanism?\",\"answer\":\"RILPL2 recruits TRIM21 to promote K48-linked ubiquitination of LDHA, leading to reduced LDHA protein stability and degradation.\"},{\"question\":\"Why is H3K18 lactylation important in this study?\",\"answer\":\"The work links inhibition of glycolysis and reduced lactate production to decreased H3K18 lactylation, which contributes to downregulation of SOX9 and SMYD2 and suppresses tumor progression.\"}]","RILPL2 suppresses metabolic reprogramming and progression of cervical cancer by attenuating LDHA protein stability and inhibiting H3K18 lactylation | PDF",1790103269,38,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d931b5adb9408216e720fb40c194987e.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d22b9e27350467b535de86f817050f5c.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f17ddc6ca0800f5c4dfb2713dc49d49.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30ca78202eae4446ce6bdce04eab0589.webp",980,1301]